These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

119 related items for PubMed ID: 25921171

  • 1. Involvement of GRP78 in the Resistance of Ovarian Carcinoma Cells to Paclitaxel.
    Zhang LY, Li PL, Xu A, Zhang XC.
    Asian Pac J Cancer Prev; 2015; 16(8):3517-22. PubMed ID: 25921171
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. [Effect of glucose regulated protein 78 on autophagy and apoptosis in ovarian epithelial carcinoma].
    Li M, Tian J, Qu Q.
    Zhonghua Fu Chan Ke Za Zhi; 2015 Nov; 50(11):848-53. PubMed ID: 26887774
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Three-dimensional collagen type I matrix up-regulates nuclear isoforms of the microtubule associated protein tau implicated in resistance to paclitaxel therapy in ovarian carcinoma.
    Gurler H, Yu Y, Choi J, Kajdacsy-Balla AA, Barbolina MV.
    Int J Mol Sci; 2015 Feb 04; 16(2):3419-33. PubMed ID: 25658796
    [Abstract] [Full Text] [Related]

  • 6. Down-regulated expression of miR-134 contributes to paclitaxel resistance in human ovarian cancer cells.
    Shuang T, Wang M, Shi C, Zhou Y, Wang D.
    FEBS Lett; 2015 Oct 07; 589(20 Pt B):3154-64. PubMed ID: 26363097
    [Abstract] [Full Text] [Related]

  • 7. [Cisplatin resistant effects of dihydrofolate reductase gene expression up-regulation in epithelial ovarian cancer].
    Li Z, Wang Q, Zhang W, Yang Z, Li L.
    Zhonghua Fu Chan Ke Za Zhi; 2015 Nov 07; 50(11):854-60. PubMed ID: 26887775
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Preliminary study of the prohibitin protein and paclitaxel resistance in ovarian cancer].
    Tang J, Cao L, Yi H, Tang C.
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2012 Dec 07; 37(12):1221-7. PubMed ID: 23281375
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Knockdown of MACC1 expression increases cisplatin sensitivity in cisplatin-resistant epithelial ovarian cancer cells.
    Zhang R, Shi H, Ren F, Li X, Zhang M, Feng W, Jia Y.
    Oncol Rep; 2016 Apr 07; 35(4):2466-72. PubMed ID: 26794135
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Small interfering RNA-mediated silencing of heat shock protein 27 (HSP27) Increases chemosensitivity to paclitaxel by increasing production of reactive oxygen species in human ovarian cancer cells (HO8910).
    Song TF, Zhang ZF, Liu L, Yang T, Jiang J, Li P.
    J Int Med Res; 2009 Apr 07; 37(5):1375-88. PubMed ID: 19930842
    [Abstract] [Full Text] [Related]

  • 17. GRP78 induced by estrogen plays a role in the chemosensitivity of endometrial cancer.
    Luvsandagva B, Nakamura K, Kitahara Y, Aoki H, Murata T, Ikeda S, Minegishi T.
    Gynecol Oncol; 2012 Jul 07; 126(1):132-9. PubMed ID: 22543280
    [Abstract] [Full Text] [Related]

  • 18. [Study on the Relationship Between XIAP Gene and Resistance of Taxol in Ovarian Cancer].
    Yue C, Li RH, Chen C, Liu H.
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2018 May 07; 49(3):337-341. PubMed ID: 30014630
    [Abstract] [Full Text] [Related]

  • 19. [Study on RNA interference silencing hMSH2 induces the reversal chemo-resistance of ovarian carcinoma cell line OC3/TAX300].
    Wang A, Li J, Li H.
    Zhonghua Fu Chan Ke Za Zhi; 2014 Mar 07; 49(3):213-7. PubMed ID: 24820308
    [Abstract] [Full Text] [Related]

  • 20. FOXM1 expression is significantly associated with chemotherapy resistance and adverse prognosis in non-serous epithelial ovarian cancer patients.
    Tassi RA, Todeschini P, Siegel ER, Calza S, Cappella P, Ardighieri L, Cadei M, Bugatti M, Romani C, Bandiera E, Zanotti L, Tassone L, Guarino D, Santonocito C, Capoluongo ED, Beltrame L, Erba E, Marchini S, D'Incalci M, Donzelli C, Santin AD, Pecorelli S, Sartori E, Bignotti E, Odicino F, Ravaggi A.
    J Exp Clin Cancer Res; 2017 May 08; 36(1):63. PubMed ID: 28482906
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.